ReviewAnti-cancer agents in medicinal chemistry2026

CD24 and Mutant p53: Emerging Therapeutic Targets in Prostate Cancer Progression.

Yin Qinzhamusu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.